Many markets are expensive – but there is still value to be had
The wild optimism surrounding US tech stocks may be looking suspiciously bubble-like, but you can still find long-term value.
If you had put $100 into big US growth stocks on 31 December, 2019, you would now have $111. Shares in these companies are currently trading not so much as though Covid-19 doesn’t exist, but as though its existence has been a positive for their businesses (which you can argue – they’re mostly tech stocks) and as though they were not already overpriced in December (harder to argue). Look at the speed and scale of the recovery of many of these stocks since March – and they are the ones most discussed in the media – and you will have only one thought: “There’s a bubble out there.”
There is still value to be had
But do not for a second think that just because US tech stocks are suffering from a gloriously exuberant bout of optimism bias, there is no long-term value in markets as a whole. There is. In both Europe and the US, says Verdad’s Brian Chingono, cheap stocks are genuinely cheap. Take the cheapest 20% in the market (the “deep value” stocks) and you will see they trade at significant discounts to their long-term averages – in Europe the discount to the 20-year average is 13%, in the US, it is 17% (although European stocks are cheaper in absolute terms).
Look to the UK (now moving out of lockdown fast) as well. Here, even with the many Covid cancellations taken into account, dividend yields are high and valuations perfectly reasonable.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Two cheap investment trusts
If you like the idea of cheap (trust me, you do), and you want to find a way to hold some of the market’s most interesting assets at a discount to their net asset value (NAV) you should also listen to our latest podcast with Nick Greenwood of Premier Miton. Greenwood runs a fund of investment trusts, chosen in large part for their price (he looks to buy at a “significant discount to their intrinsic value”). We talk about many of the ones he is interested in at the moment on the podcast but one of particular interest might be Artemis Alpha (LSE: ATS), a trust with a history of making unsuccessful private investments and underperforming as a result. Two years ago it relaunched with new managers. The unlisted holdings have been significantly cut (to below 10%) and matters are much improved. However you can still buy the revamped portfolio at a 19% discount.
I’m also interested in Henderson Opportunities (LSE: HOT) – run by James Henderson and Laura Foll who also run Law Debenture (one of the trusts in the MoneyWeek model portfolio). This trust is more focused on small caps than the latter and if you have any faith in the stock picking abilities and value bias of the fund managers (which we do) the shares should be pretty interesting on a discount of 20% to their NAV. If investment trusts on discounts are your thing (they probably should be) Max King looks at the private equity sector in this week's magazine.
Finally a reminder that where and whenever you invest you should do so with at least some thought (see John’s Money Morning newsletter from 24 June) – we look this week at the shocking story of what can happen when you don’t. I really hope none of you went into last week holding Wirecard.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
Higher rates are disappearing – should you fix your savings?
Fixed savings rates have dropped to their lowest levels in over a year. Should you fix your savings now ahead of a potential base rate cut in November?
By Katie Williams Published
-
Nine million people fall victim to financial scams, says Citizens Advice
The charity says that around one in five people across the UK have been caught out by a finance scam in the past year - here is how to protect your money
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published